Position in IQV
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$9,717,710
+$1,999,898 QoQ
Shares Held
56,982
+66.4% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IQV Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026MACKENZIE FINANCIAL CORP holds $584,341,661 across 19 Diagnostics & Research names. IQV ranks #7 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
1,214,467 | $230,262,943 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
222,589 | $109,409,171 | |
| 3 | CRL |
Charles River Laboratories International, Inc.
|
594,800 | $102,603,000 | |
| 4 | WAT |
Waters Corp /De/
|
145,950 | $43,463,910 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
45,739 | $25,700,286 | |
| 6 | DGX |
Quest Diagnostics Inc
|
126,510 | $24,793,429 | |
| 7 | IQV |
Iqvia Holdings Inc.
This page
|
56,982 | $9,717,710 | |
| 8 | A |
Agilent Technologies, Inc.
|
80,960 | $9,227,820 |
All Filings in IQV
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,717,710 | 56,982 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $7,717,812 | 34,239 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $6,540,014 | 34,432 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $5,759,284 | 36,546 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $6,167,855 | 34,985 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $8,877,535 | 45,176 | Shares | Sole | 2025-05-02 | |
| 2024-09-30 | $25,685,652 | 108,392 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $19,567,291 | 92,543 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $21,083,439 | 83,370 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $9,655,024 | 41,728 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $8,174,962 | 41,550 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $12,367,744 | 55,024 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $76,142,848 | 382,839 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $79,980,245 | 390,357 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $62,181,920 | 343,281 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $71,217,853 | 328,208 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $72,751,382 | 314,655 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $88,422,111 | 313,398 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,652,665 | 11,074 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $1,861,259 | 7,681 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $1,378,633 | 7,138 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $738,897 | 4,124 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $574,561 | 3,645 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $506,369 | 3,569 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||